Dubai - United Arab Emirates
+919595453000

Nausea and vomiting due to chemotherapy by Aprecap I.v.

Fosaprepitant Dimeglumine 150mg

In stock

Description

APRECAP I.V. 150 mg Injection contains Fosaprepitant Dimeglumine (150 mg per vial) as its active salt/composition, which acts as a water-soluble phosphoryl prodrug of aprepitant and a neurokinin-1 (NK1) receptor antagonist